PHARMAZEUTISCHE FORMULIERUNGEN

Patent europeic · EP4106727 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4106727
Numer da la dumonda
EP21706537
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-02-2021
Publitgà
28-12-2022
Concedì
04-11-2026
La protecziun finescha il pli tard
16-02-2041
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61K 9/08 (2006.01)
A61K 9/00 (2006.01)
A61K 45/06 (2006.01)
A61K 47/02 (2006.01)
A61K 47/18 (2017.01)
Prioritad
EP 20157963 18.02.2020
EP 20171240 24.04.2020
EP 20180645 17.06.2020
EP 20180832 18.06.2020
EP 21150056 04.01.2021
EP 21151004 11.01.2021
EP 21154657 02.02.2021
Dumonda PCT
PCT/EP2021/053805 17.02.2021
Publicaziun PCT
WO2021/144476 22.07.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-11-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.11.2026

Partidas

Inventur

SANDER, Tommy

2880 Bagsværd, DK

POULSEN, Christian

2880 Bagsværd, DK

HANSEN, Rosa, Rebecca, Erritzøe

2880 Bagsværd, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.